NCT00228930View on ClinicalTrials.gov

Tamoxifen Pharmacogenetics and Clinical Effects

CompletedOBSERVATIONAL
Enrollment

297

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2007

Conditions
Breast Cancer
Interventions
DRUG

Tamoxifen (pharmacodynamic analysis)

Tamoxifen 20mg po daily

Trial Locations (2)

46202

Indiana University, Indianapolis

48109

UMCCC, Ann Arbor

All Listed Sponsors
collaborator

Indiana University School of Medicine

OTHER

lead

National Institute of General Medical Sciences (NIGMS)

NIH

NCT00228930 - Tamoxifen Pharmacogenetics and Clinical Effects | Biotech Hunter | Biotech Hunter